The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
D
|
Dizal Pharmaceutical Co Ltd
SSE:688192
|
CN |
|
Istyle Inc
TSE:3660
|
JP |
|
S
|
Stellantis NV
XHAM:8TI
|
NL |
|
Tyler Technologies Inc
NYSE:TYL
|
US |
|
S
|
Shanghai Tunnel Engineering Co Ltd
SSE:600820
|
CN |
|
Trivago NV
NASDAQ:TRVG
|
DE |
|
W
|
Wynn Resorts Ltd
SWB:WYR
|
US |
|
S
|
Starbucks Corp
XHAM:SRB
|
US |
|
Compagnie Generale des Etablissements Michelin SCA
PAR:ML
|
FR |
|
S
|
Swire Pacific Ltd
HKEX:87
|
HK |
|
Stabilis Solutions Inc
NASDAQ:SLNG
|
US |
|
CVB Financial Corp
NASDAQ:CVBF
|
US |
|
P
|
PSP Swiss Property AG
SWB:P7S
|
CH |
|
L
|
London Stock Exchange Group PLC
F:LS4C
|
UK |
|
Barco NV
OTC:BCNAF
|
BE |
|
S
|
Societe Generale SA
DUS:SGE
|
FR |
|
Bozhon Precision Industry Technology Co Ltd
SSE:688097
|
CN |
|
Gudang Garam Tbk PT
F:GGG
|
ID |
Dizal Pharmaceutical Co Ltd (688192)’s 12-month stock price forecast through September 2027 has a consensus target of ¥84.66, implying 46% upside. The forecast is based on price targets from 3 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for Dizal Pharmaceutical Co Ltd is 84.66 CNY with a low forecast of 83.83 CNY and a high forecast of 87.15 CNY.
Over the last 6 years, the compound annual growth rate for Revenue has been 64%. The projected CAGR for the next 5 years is 65%.
Over the last 6 years, the compound annual growth rate for Gross Profit has been 130%. The projected CAGR for the next 2 years is 52%.
AI-generated answers can contain mistakes, outdated facts, or incomplete information. Always verify important details before making decisions.
The AI Assistant is designed for research and education. It does not provide personalized investment, legal, or tax advice.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more